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© 2011 Japanese Society of Tropical Medicine Abstract: Dengue virus is an arthropod-borne virus transmitted by Aedes mosquitoes. Dengue virus causes fever
and hemorrhagic disorders in humans and non-human primates. Direct interaction of the virus introduced by a
mosquito bite with host receptor molecule(s) is crucial for virus propagation and the pathological progression of
dengue diseases. Therefore, elucidation of the molecular mechanisms underlying the interaction between dengue
virus and its receptor(s) in both humans and mosquitoes is essential for an understanding of dengue pathology. In
addition, understanding the molecular mechanism(s) of virus entry is crucial for the development of effective new
therapies to treat dengue patients. Binding of dengue virus to its receptor molecules is mediated through a viral
envelope glycoprotein, termed E protein. We present a summary and describe the structures, binding properties,
and pathological relevance of dengue virus receptor molecules proposed to date. In mammalian cells, there are
many candidate molecules that may act as receptors, such as sulfated glycosaminoglycans (GAGs), lectins that
recognize carbohydrates, glycosphingolipid (GSL), proteins with chaperone activity, laminin-binding proteins, and
other uncharacterized proteins. There are also several lines of evidence for receptor molecules such as GSLs, proteins
with chaperone activity, laminin-binding proteins, and other uncharacterized proteins in mosquito cells and organs.
This review focuses on several molecules involved in carbohydrate-dependent binding of the virus.
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INTRODUCTION
Epidemic dengue virus (DENV) has rapidly expanded
its range through tropical and subtropical regions in recent
years. This pathogen causes febrile illness (dengue fever,
DF) and severe bleeding disease (dengue hemorrhagic fever,
DHF) in humans. DF and DHF, with an estimated annual
infection rate of 100 million and approximately 500,000
deaths, are the most infectious diseases in tropical and
subtropical regions. Dengue virus is transmitted between
humans and the arthropod host (mosquito), forming a dis-
tinctive ring and showing that humans are not the terminal
host. Infection of humans with the virus is primarily
mediated by the Aedes mosquito. The virus grows in the
mosquito gut and migrates to the salivary glands. When an
infected mosquito feeds on a healthy person, the virus is
inoculated subcutaneously [1–3]. Dengue virus primarily
propagates in skin dendritic cells, and subsequently virus
proliferation is thought to occur in target cells such as those
of the monocyte/macrophage lineage [4].
There are four dengue virus serotypes, i.e., types 1–4.
Neutralizing antibodies are specifically induced by initial
infection with each virus serotype, and lifelong immunity is
established for the same type of virus. In most cases of
initial infection, the host develops dengue fever, which has
a mild prognosis. Cross-neutralizing antibodies against
different serotypes disappear within a short period, and a
virus of another serotype may cause reinfection (secondary
infection). When secondary infection by a different sero-
types occurs, the immune complexes of the viruses with
cross-reactive antibodies produced during primary infection
enhance viral infection mediated through Fcγ receptor-
dependent incorporation of the virus into host cells. There
is a strong possibility that such a progressive response
contributes to more severe manifestations, such as DHF and
dengue shock syndrome [5–10].
Dengue virus is an enveloped virus about 50 nm in
diameter. The envelope glycoprotein (E protein) is present
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on the viral membrane (Fig. 1). E protein is a functional
protein molecule that binds to receptors on the host cell
membrane; it is also a major antigen against host protective
immunity, which induces neutralizing antibody [11–13]. E
protein is divided into three functional domains, termed
domains I, II, and III. Domain I, the hinge region, is linked
to the two other functional domains. The high mobility of
this region is responsible for the changes in structure of E
protein due to variations in external pH. Domain II has a
hydrophobic-rich peptide sequence featuring the membrane
fusion activity and contributes to E protein dimerization
[14–16]. Domain III is thought to be involved in the binding
to receptor molecules present on the host cell membrane
(Fig. 1). During viral infection, the adsorption of viral parti-
cles is initiated by binding of E protein to receptor mole-
cules present on the host cell membrane. Subsequently, the
adsorbed viruses are taken into the cell by endocytosis. The
pH decreases inside endosomes formed by fusion with lyso-
somes, and the viral membrane is fused with the endosomal
membrane mediated through the action of the E protein
fusion peptide. Eventually, the nucleocapsid enters the cyto-
plasm, and the virus genome is released into the cytoplasm.
Direct interaction of the virus with host receptor
molecule(s) is crucial for virus propagation and the patho-
logical progression of dengue diseases. Elucidation of the
molecular mechanisms underlying interaction of dengue
virus with its receptor(s) in humans and mosquitoes is
essential for an understanding of dengue pathology. To date,
many candidate molecules have been proposed as dengue
receptors. In this review article, we present a summary and
describe the structures, binding properties, and pathological
relevance of dengue virus receptor molecules proposed in
these previous studies.
Fig. 1.  DENV E protein interacts with lectin and other molecules expressed on the host cell surface. N-Glycan at position 67 is
recognized by DC-SIGN, and N-glycans at positions 67 and/or 153 may be associated with host lectin proteins, such as
mannose-binding protein. E protein consists of three functional domains. Domain I (red) is a flexible hinge region that con-
tributes to the conformational change of the protein under low pH conditions in endosomes. Domain II (yellow) contains hy-
drophobic amino acid residues that form a fusion loop at the tip of the domain. In addition, this domain may contribute to
dimerization of the protein on the mature virus membrane. Finally, domain III (blue) is thought to be responsible for the direct
interaction with host receptor molecules. The structure represents E protein of DENV3, which was modeled using PyMol
with PDB accession number 1UZG.39 K.I.P.J. Hidari et al.
DENGUE VIRUS RECEPTORS 
IN MAMMALIAN CELLS
Halstead et al. first demonstrated that dengue virus
infection in human peripheral blood leukocytes was
enhanced by the presence of non-neutralizing antibody [5–
10]. This enhancement was mediated through Fcγ receptors
expressed on leukocytes. These findings indicated that Fc
receptor-mediated entry is involved in secondary infection,
particularly infection with a serotype different from that in-
volved in primary infection. With regard to primary infec-
tion and initial contact of the virus with host cells, investi-
gations to identify receptor molecules have been performed
in mammalian cells. Table 1 presents a summary of dengue
virus receptors in mammalian cells proposed in previous
studies. The candidate molecules can be categorized into
four major groups. First, carbohydrate molecules such as
sulfated glycosaminoglycans (GAGs) and glycosphingolipid
(GSL) are thought to act as co-receptor molecules, which
enhance the efficiency of virus entry. Among the sulfated
GAGs, heparan sulfate is indispensable for virus adsorption
to the host cells [17–19]. Another type of carbohydrate
molecule has recently been reported to contribute to virus
attachment; neolactotetraosylceramide (nLc4Cer), a GSL
without sulfation, may also be a co-receptor on the host
cells [20]. Native and (semi)synthetic forms of carbohydrate
compounds derived from GAG and GSL structures success-
fully inhibited DENV infection of different cell types [17–
20, 21]. These findings strongly suggest that carbohydrate
molecules in the extracellular matrix are positively involved
in DENV propagation in target cells. Second, carbohydrate-
binding proteins, termed lectins, expressed on dendritic
cells (DCs) and macrophages under the human skin are
involved in initial contact of DENV introduced by mosquito
bite. Among these lectins, dendritic cell-specific inter-
cellular adhesion molecule-3-grabbing non-integrin (DC-
SIGN) has been best characterized in virus-DC interaction
[22–24]. Cryoelectron microscopic analysis demonstrated
that recombinant lectin protein binds directly to N-glycans
at position of 67 of E protein expressed on viral particles
(Fig. 1). DC-SIGN-mediated entry allows DENV to propa-
gate in DC, meaning that DC is the primary target for
DENV. A recent study showed that another lectin, mannose
receptor, contributes to the entry of DENV into macroph-
ages [25]. Taken together, the above observations indicate
that carbohydrate recognition events are associated with
DENV propagation in the human body. Third, factors related
to protein folding, such as heat shock proteins [26] and
chaperones [27–29], may also be involved in the interaction
of DENV serotype 2 (DENV-2) and host cells. It has been
reported that a single serotype, DENV-2, bound these
molecules. Fourth, independent studies showed that other
Table 1. Dengue virus receptors (mammalian) proposed in the previous studies
Mw: molecular weight of interested protein.
CHO-dpd binding: carbohydrate-dependent binding.
Receptor Properties Cell/Tissue expression Serotype References
Heparan sulfate Sulfated glycosaminoglycan Vero cells, BHK-21 cells 
SW-13 cells
DENV1–4 17–19
nLc4Cer Glycosphingolipid Vero cells, BHK-21 cells, 
K562 cells
DENV1–4 20
DC-SIGN/L-SIGN Dendritic cell-specific lectin, CD209 Dendritic cells, Macrophage DENV-1–4 22–24
Mannose receptor Protein with lectin activity Macrophage DENV-1–4 25




GRP78 Expression on plasma membrane 
Chaperon
HepG2 cells DENV-2 27–29
Laminin receptor High-affinity laminin receptor PS Clone D cells, HepG2 cells DENV-1–3 30, 31
MW: 37/67 kDa
CD14-associated protein Protein associated with LPS receptor Monocyte, Macrophage DENV-2 32
Unknown glycoproteins CHO-dpd binding Vero cells DENV-4 33
MW: 44/74 kDa
Unknown protein Trypsin-resistant ECV304 cells DENV-2 34
MW: 29 kDa




Unknown proteins Serotype-specific binding HepG2 cells DENV-2–4 36
MW: 78-182 kDa40 Tropical Medicine and Health Vol.39 No.4 Supplement, 2011
proteins, including high-affinity laminin receptor [30, 31],
CD14-associated protein [32], and uncharacterized proteins
[33–36], may also be involved in DENV—host cell interac-
tion. Some of these proteins reported to date may be identical
with regard to properties, such as molecular mass. Some of
the proposed receptors are commonly recognized by different
serotypes of DENV, while others seem to interact specifi-
cally with a certain serotype of DENV. These findings
strongly suggest that DENV binds multiple molecules that
may form complexes on host cells, and that DENV uses
specific combinations of receptor candidates to enter differ-
ent types of cell. However, the nature of cellular receptors
and molecular mechanisms for dengue virus entry has not
yet been fully elucidated.
DENGUE VIRUS RECEPTORS IN MOSQUITO CELLS
Table 2 summarizes the major receptor molecules
proposed in previous studies. In contrast to mammalian
receptors, candidate molecules in mosquitoes are mostly
proteins. Virus overlay protein binding assay demonstrated
that particular proteins with certain molecular masses
reacted on the membrane specifically with DENV particles
or recombinant E protein in some cases. Laminin-binding
protein from C6/36 cells is a possible high-affinity laminin
receptor which is analogous to a molecule proposed as a
receptor in mammalian HepG2 cells [37]. Several lines of
evidence suggested that HSP90-related proteins may be
receptor molecules in a mosquito cell line as well as organs
such as the salivary glands, midgut, and ovary [38–41].
These studies also revealed receptor candidates with similar
protein properties in two different species of mosquitoes,
Aedes albopictus and Aedes aegypti, which can commonly
transmit DENV to humans. However, the properties of the
proposed proteins have not been fully determined [42–47].
Similar to mammalian receptors, a recent study showed that
GSLs specifically related to mosquitoes reacted with DENV-
2 particles [48]. However, previous studies demonstrated
that heparin, one of the GAGs, did not bind to DENV,
indicating that sulfated polysaccharides do not contribute
significantly to DENV entry into mosquito cells [21, 37].
Thus, the nature of the mosquito receptors has yet to be
elucidated, and further investigations are required to identify
these molecules.
OTHER FLAVIVIRUS RECEPTORS
Previous studies demonstrated that two encephalitis
flaviviruses, Japanese encephalitis virus (JEV) and West
Nile virus (WNV), bind to sulfated GAGs, such as heparin
sulfate and chondroitin sulfate E [17, 19]. These observa-
tions indicated that these sulfated polysaccharides may be
commonly recognized by flaviviruses regardless of virus
type in mammalian cells. Among protein candidates in
mammalian cells, the best characterized is integrin αvβ3 as a
receptor for WNV [49]. This heterodimer protein seems to
be specifically recognized by WNV, but not DENV or JEV.
In mosquito cells, there are several proteins that have been
Table 2. Dengue virus receptors (Aedes mosquito) proposed in the previous studies
Mw: molecular weight of interested protein.
CHO-indp binding: carbohydrate-independent binding.
Receptor Properties Cell/Tissue expression Serotype References
Laminin-binding protein Possible high-affinity laminin receptor C6/36 cells (A. albopictus)D E N V - 3 , 4 3 7
Mw: 50 kDa
Unknown glycoprotein Cell-surface protein, CHO-indp binding 
HSP90-related protein
C6/36 cells (A. albopictus) 
Salivary glands, midgut, ovary, 
malpighian tubules (A. aegypti)
DENV-2,4 38–41
Mw: 40, 45 and 74 kDa
Ar3Cer nLc4Cer Neutral glycosphingolipids C6/36 cells (A. albopictus)D E N V - 2 4 2
Prohibitin Membrane-associated protein 
Mw: 35 kDa
C6/36 cells (A. albopictus) 
CCL-125 cells (A. aegypti) 
Mosquito whole body (A. aegypti)
DENV-2 43
Tublin-like protein Cytosolic protein C6/36 cells (A. albopictus)D E N V - 2 4 4
Mw: 48 kDa
Unknown proteins Cell-surface proteins 
Mw: 67 and 80 kDa
C6/36 cells (A. albopictus) 
Midgut (A. aegypti)
DENV-1–4 45, 46
Unknown protein Cell-surface protein 
Marker of vector competence
Midgut (A. aegypti)D E N V - 2 4 7
Mw: 67 kDa
Unknown proteins Several detergent-soluble proteins Salivary glands 
(A. aegypti, A. polynesiensis)
DENV-1–4 48
Mw: 35–80 kDa41 K.I.P.J. Hidari et al.
proposed as receptors for WNV [50–52]. However, the
nature of these proteins in mosquito cells is yet to be fully
elucidated. These other flavivirus receptors proposed are
listed in Table 3.
CONCLUSION
Dengue virus is transmitted from human to human by
mosquitoes. Thus, this virus can efficiently infect and pro-
liferate in both humans and mosquitoes as hosts. Over the
past 30 years, many studies have been performed to identify
and characterize host receptor(s) for dengue virus. Several
molecules have been proposed as possible receptors in
human and mosquito cells and tissues.
In mammalian cells, sulfated glycosaminoglycans
(GAGs), lectins that recognize carbohydrates, glycosphin-
golipid (GSL), laminin-binding proteins, GSLs, chaperone
proteins, and undefined proteins have been reported as
candidates. Independent studies by different groups strongly
suggested that heparan sulfate and DC-SIGN are indispens-
able for dengue virus infection in humans. Heparan sulfate
is thought to be a co-receptor, which associates with other
molecules to form functional complexes and enhances the
efficiency of virus infection into host cells. DENV infects
dendritic cells mediated through DC-SIGN specifically
expressed on the cells. As virus-infected dendritic cells
move to the peripheral lymph nodes where the virus is
propagated and disseminated into blood, this molecule acts
as the primary receptor for the virus. Several studies
supported the suggestion that carbohydrate molecules in
extracellular matrix are strongly related to DENV receptors.
One of the major differences from the case of mam-
malian cells is the fact that GAGs are not significantly
involved in viral infection of mosquito cells. To date,
laminin-binding proteins, GSLs, and other undefined pro-
teins have been proposed in mosquito cells and organs.
These findings suggested that molecules distinct from those
in mammals contribute to interaction between the virus and
host cells in mosquitoes.
Elucidation of the molecular mechanisms underlying
the interaction of dengue virus with receptor(s) in humans
and mosquitoes is essential for an understanding of dengue
pathology. In addition, understanding the molecular mecha-
nism(s) of virus entry is crucial for the development of
effective new therapies to treat dengue patients. Further
investigations to elucidate the nature of the molecular
complex of DENV receptor are required.
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